Scanogen Inc.


Scanogen is a molecular diagnostic company focused on developing rapid and ultra-sensitive detection systems for biomolecules in body fluids. Utilizing their proprietary Single MOLecule Tethering (SMOLT) technology, Scanogen aims to improve healthcare by providing quick and actionable diagnostic results, particularly in the areas of bloodstream and respiratory infections.

Scanogen Inc. Logo

Scanogen Inc.

3102 Lord Baltimore Dr., Suite 214, Baltimore, MD, 21244


Patents

Detection units and methods for detecting a target analyte

2025-05-06 • US-12291741-B2

View Details

Detection units and methods for detecting a target analyte

2022-11-22 • US-11505818-B2

View Details

Detection units and methods for detecting a target analyte

2022-06-28 • US-11371986-B2

View Details

Detection units and methods for detecting a target analyte

2019-01-15 • US-10179930-B2

View Details

Detection units and methods for detecting a target analyte

2016-07-05 • US-9382580-B2

View Details

Detection units and methods for detecting a target analyte

2016-07-05 • US-9382578-B2

View Details

What We Do

A revolutionary platform technology for ultra-sensitive and rapid detection of nucleic acids and microorganisms in body fluids, enabling direct detection in whole blood, saliva, sputum, and urine.

An assay under development for rapid identification of bloodstream pathogens, providing results in 60 minutes without the need for blood culture.


Diagnostics


News & Updates

Granted for a novel method to eliminate background noise in assays based on a solid substrate.

Covers the optical system used in SMOLT, including an imaging system to determine the position or movement of particles over a large field of view.

Covers Single Molecule Tethering (SMOLT) technology, including detection of molecules using long probes.

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.